Laterza OF - Search Results

1

Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays.

Qiu P, Poehlein CH, Marton MJ, Laterza OF, Levitan D. Qiu P, et al. Among authors: laterza of. Sci Rep. 2019 Jan 14;9(1):114. doi: 10.1038/s41598-018-37128-y. Sci Rep. 2019. PMID: 30643180 Free PMC article.

2

Analytical validation of quantitative immunohistochemical assays of tumor infiltrating lymphocyte biomarkers.

Singh U, Cui Y, Dimaano N, Mehta S, Pruitt SK, Yearley J, Laterza OF, Juco JW, Dogdas B. Singh U, et al. Among authors: laterza of. Biotech Histochem. 2018;93(6):411-423. doi: 10.1080/10520295.2018.1445290. Epub 2018 Jun 4. Biotech Histochem. 2018. PMID: 29863904

3

The clinical utility of mass spectrometry based protein assays.

Lassman ME, McAvoy T, Chappell DL, Lee AY, Zhao XX, Laterza OF. Lassman ME, et al. Among authors: laterza of. Clin Chim Acta. 2016 Aug 1;459:155-161. doi: 10.1016/j.cca.2016.05.027. Epub 2016 Jun 1. Clin Chim Acta. 2016. PMID: 27259466 Review.

4

A clinical biomarker assay to quantitate thymic stromal lymphopoietin in human plasma at sub-pg/ml level.

Zhao X, Ayanoglu G, Bilardello M, Fayadat-Dilman L, Zhang JH, Li HL, Bald L, Mcclanahan T, de Waal Malefyt R, Weiner R, Laterza OF. Zhao X, et al. Among authors: laterza of. Bioanalysis. 2015;7(5):573-82. doi: 10.4155/bio.14.297. Bioanalysis. 2015. PMID: 25826139

5

An ultrasensitive method for the quantitation of active and inactive GLP-1 in human plasma via immunoaffinity LC-MS/MS.

Chappell DL, Lee AY, Castro-Perez J, Zhou H, Roddy TP, Lassman ME, Shankar SS, Yates NA, Wang W, Laterza OF. Chappell DL, et al. Among authors: laterza of. Bioanalysis. 2014 Jan;6(1):33-42. doi: 10.4155/bio.13.280. Bioanalysis. 2014. PMID: 24341493

6

Plasma MicroRNAs as sensitive and specific biomarkers of tissue injury.

Laterza OF, Lim L, Garrett-Engele PW, Vlasakova K, Muniappa N, Tanaka WK, Johnson JM, Sina JF, Fare TL, Sistare FD, Glaab WE. Laterza OF, et al. Clin Chem. 2009 Nov;55(11):1977-83. doi: 10.1373/clinchem.2009.131797. Epub 2009 Sep 10. Clin Chem. 2009. PMID: 19745058

7

Multiplexed Quantification of Proglucagon-Derived Peptides by Immunoaffinity Enrichment and Tandem Mass Spectrometry after a Meal Tolerance Test.

Lee AY, Chappell DL, Bak MJ, Judo M, Liang L, Churakova T, Ayanoglu G, Castro-Perez J, Zhou H, Previs S, Souza SC, Lassman ME, Laterza OF. Lee AY, et al. Among authors: laterza of. Clin Chem. 2016 Jan;62(1):227-35. doi: 10.1373/clinchem.2015.244251. Epub 2015 Oct 1. Clin Chem. 2016. PMID: 26430077

8

Development and fit-for-purpose validation of a LC-MS/MS assay for fibrinogen peptide A quantitation in human plasma.

Lin M, Lassman ME, Weiner R, Laterza OF. Lin M, et al. Among authors: laterza of. Bioanalysis. 2014;6(13):1759-66. doi: 10.4155/bio.14.148. Bioanalysis. 2014. PMID: 25157483

9

An LC-MRM method for measuring intestinal triglyceride assembly using an oral stable isotope-labeled fat challenge.

Li X, Parks EJ, McLaren DG, Lambert JE, Cardasis HL, Chappell DL, McAvoy T, Salituro G, Alon A, Dennie J, Chakravarthy M, Shankar SS, Laterza OF, Lassman ME. Li X, et al. Among authors: laterza of. Bioanalysis. 2016 Jun;8(12):1265-77. doi: 10.4155/bio-2016-0024. Epub 2016 May 26. Bioanalysis. 2016. PMID: 27225968

10

A Machine Learning Approach to Identify a Circulating MicroRNA Signature for Alzheimer Disease.

Zhao X, Kang J, Svetnik V, Warden D, Wilcock G, David Smith A, Savage MJ, Laterza OF. Zhao X, et al. Among authors: laterza of. J Appl Lab Med. 2020 Jan 1;5(1):15-28. doi: 10.1373/jalm.2019.029595. J Appl Lab Med. 2020. PMID: 31811079 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page